Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections
出版年份 2019 全文链接
标题
Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-06-19
DOI
10.3389/fmicb.2019.01327
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- New therapies for acute RSV infections: where are we?
- (2019) Ying Xing et al. EUROPEAN JOURNAL OF PEDIATRICS
- Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond
- (2018) Shuvam Chaudhuri et al. ANTIVIRAL RESEARCH
- Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference
- (2018) Jennifer L. McKimm-Breschkin et al. ANTIVIRAL RESEARCH
- Isosteric ribavirin analogues: Synthesis and antiviral activities
- (2018) Nikolay I. Zhurilo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches
- (2018) Sara A. Taleb et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Second-generation nitazoxanide derivatives: thiazolides are effective inhibitors of the influenza A virus
- (2018) Andrew V Stachulski et al. Future Medicinal Chemistry
- A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases
- (2018) Emily J Erbelding et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study
- (2018) John H Beigel et al. LANCET INFECTIOUS DISEASES
- Safety, Tolerability, and Pharmacokinetics of MEDI8897, an Extended Half-Life Single-Dose Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants
- (2018) Joseph B. Domachowske et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients After Liver Transplantation
- (2018) Teresa Maria Antonini et al. TRANSPLANTATION
- Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial
- (2018) Yaseen M. Arabi et al. Trials
- Economic burden of seasonal influenza in the United States
- (2018) Wayan C.W.S. Putri et al. VACCINE
- Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models
- (2018) Ji-Ae Kim et al. Viruses-Basel
- Advancements in Host-Based Interventions for Influenza Treatment
- (2018) Tsz-Fung Yip et al. Frontiers in Immunology
- Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review
- (2018) Sabeena Mustafa et al. Journal of Infection and Public Health
- Evaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated Influenza
- (2018) S. Omar Ali et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Post-exposure prophylaxis for Middle East respiratory syndrome in Healthcare workers
- (2018) So Yeon Park et al. JOURNAL OF HOSPITAL INFECTION
- Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
- (2018) Frederick G. Hayden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating Influenza Infection, From Now and Into the Future
- (2018) Sophia Davidson Frontiers in Immunology
- In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit
- (2018) Takeshi Noshi et al. ANTIVIRAL RESEARCH
- Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection
- (2018) Keita Fukao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Author Correction for Jones et al., “Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors”
- (2018) Jeremy C. Jones et al. mBio
- Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil
- (2018) Emi Takashita et al. Frontiers in Microbiology
- RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations
- (2017) Richard L. Wasserman et al. Expert Review of Clinical Immunology
- The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution
- (2017) Louise Ormond et al. Genome Biology and Evolution
- The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin
- (2017) Young-In Kim et al. Influenza and Other Respiratory Viruses
- Influenza antivirals currently in late-phase clinical trial
- (2017) Paulina Koszalka et al. Influenza and Other Respiratory Viruses
- A cohort-study of patients suspected for MERS-CoV in a referral hospital in Saudi Arabia
- (2017) Jaffar A. Al-Tawfiq et al. JOURNAL OF INFECTION
- The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses
- (2017) Catharine I Paules et al. JOURNAL OF INFECTIOUS DISEASES
- A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective
- (2017) Ali A. Rabaan et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Nanobodies® † †Nanobody is a registered trademark of Ablynx NV. as inhaled biotherapeutics for lung diseases
- (2017) Gino Van Heeke et al. PHARMACOLOGY & THERAPEUTICS
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Middle East respiratory syndrome (MERS) coronavirus and dromedaries
- (2017) Ulrich Wernery et al. VETERINARY JOURNAL
- Zoonotic origin and transmission of Middle East respiratory syndrome coronavirus in the UAE
- (2017) C. R. Paden et al. Zoonoses and Public Health
- Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
- (2017) Daiyin Tian et al. Nature Communications
- Tratamiento antigripal: fármacos actualmente utilizados y nuevos agentes en desarrollo
- (2017) Luciano Amarelle et al. ARCHIVOS DE BRONCONEUMOLOGIA
- The Next Wave of Influenza Drugs
- (2017) Megan L. Shaw ACS Infectious Diseases
- Respiratory syncytial virus: prospects for new and emerging therapeutics
- (2017) Patricia A. Jorquera et al. Expert Review of Respiratory Medicine
- Middle East respiratory syndrome coronavirus: five years later
- (2017) Ali A. Rabaan Expert Review of Respiratory Medicine
- Human monoclonal antibodies as candidate therapeutics against emerging viruses
- (2017) Yujia Jin et al. Frontiers of Medicine
- Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers
- (2016) Jeremy J. Lim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults
- (2016) M. Pamela Griffin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice
- (2016) Donald F. Smee et al. ANTIVIRAL RESEARCH
- Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir
- (2016) Emi Takashita et al. ANTIVIRAL RESEARCH
- Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia
- (2016) Mohammed Al Ghamdi et al. BMC INFECTIOUS DISEASES
- Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
- (2016) Nicole L. Kallewaard et al. CELL
- Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
- (2016) Cameron Griffiths et al. CLINICAL MICROBIOLOGY REVIEWS
- Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
- (2016) Jaffar A. Al-Tawfiq et al. Expert Review of Anti-Infective Therapy
- A review of treatment modalities for Middle East Respiratory Syndrome
- (2016) Yin Mo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients
- (2016) Jens Gottlieb et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo
- (2016) Thomas Luke et al. Science Translational Medicine
- Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections
- (2016) Malak M. Alame et al. Frontiers in Microbiology
- Effect of Oral JNJ-53718678 (JNJ-678) on Disease Severity in Healthy Adult Volunteers Experimentally Inoculated With Live Respiratory Syncytial Virus (RSV): A Placebo-Controlled Challenge Study
- (2016) Samuel Israel et al. Open Forum Infectious Diseases
- GS-5806 Inhibits Pre- to Postfusion Conformational Changes of the Respiratory Syncytial Virus Fusion Protein
- (2015) Dharmaraj Samuel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of a Large Cluster of Influenza A(H1N1)pdm09 Viruses Cross-Resistant to Oseltamivir and Peramivir during the 2013-2014 Influenza Season in Japan
- (2015) Emi Takashita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
- (2015) Laurent Detalle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase 1 clinical trials of DAS181, an inhaled sialidase, in healthy adults
- (2015) Jonathan M. Zenilman et al. ANTIVIRAL RESEARCH
- Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome: a case report
- (2015) Uh Jin Kim et al. ANTIVIRAL THERAPY
- Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors
- (2015) Michael J. Boyd et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Middle East Respiratory Syndrome– advancing the public health and research agenda on MERS- lessons from the South Korea outbreak
- (2015) Eskild Petersen et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma
- (2015) Xiao-Xin Wu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study
- (2015) Sarah Shalhoub et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Palivizumab epitope–displaying virus-like particles protect rodents from RSV challenge
- (2015) Jeanne H. Schickli et al. JOURNAL OF CLINICAL INVESTIGATION
- Middle East respiratory syndrome coronavirus (MERS-CoV): what lessons can we learn?
- (2015) A.S. Omrani et al. JOURNAL OF HOSPITAL INFECTION
- Passive Immunotherapy with Dromedary Immune Serum in an Experimental Animal Model for Middle East Respiratory Syndrome Coronavirus Infection
- (2015) Jincun Zhao et al. JOURNAL OF VIROLOGY
- Middle East respiratory syndrome
- (2015) Alimuddin Zumla et al. LANCET
- Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial
- (2015) Katherine L O'Brien et al. LANCET INFECTIOUS DISEASES
- Molecular mechanism of respiratory syncytial virus fusion inhibitors
- (2015) Michael B Battles et al. Nature Chemical Biology
- Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study
- (2015) John P. DeVincenzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
- (2015) Kristen E. Pascal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate
- (2015) Jerome Deval et al. PLoS Pathogens
- Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures
- (2015) Sara M. Johnson et al. PLoS Pathogens
- Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
- (2015) Yaseen Arabi et al. SpringerPlus
- Phase 1 Study Evaluating Safety, Tolerability, Pharmacokinetics and Immunogenicity of REGN2222 in Healthy Adults: A New Human Monoclonal RSV-F Antibody for RSV Prevention
- (2015) Sumathi Sivapalasingam et al. Open Forum Infectious Diseases
- Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model
- (2015) Gabriela Ispas et al. PLoS One
- Synergistic Effect of Nitazoxanide with Neuraminidase Inhibitors against Influenza A VirusesIn Vitro
- (2014) Giuseppe Belardo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral Susceptibility of Variant Influenza A(H3N2)v Viruses Isolated in the United States from 2011 to 2013
- (2014) K. Sleeman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit
- (2014) Randal A. Byrn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Action for Respiratory Syncytial Virus Inhibitor RSV604
- (2014) SreeRupa Challa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ribavirin and interferon (IFN)-alpha-2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus (MERS-CoV): a preliminary report of two cases
- (2014) Mohammed Khalid et al. ANTIVIRAL THERAPY
- Broadly Neutralizing Influenza Hemagglutinin Stem-Specific Antibody CR8020 Targets Residues that Are Prone to Escape due to Host Selection Pressure
- (2014) Kannan Tharakaraman et al. Cell Host & Microbe
- Clinical and Laboratory Findings of the First Imported Case of Middle East Respiratory Syndrome Coronavirus to the United States
- (2014) Minal Kapoor et al. CLINICAL INFECTIOUS DISEASES
- Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
- (2014) Jaffar A. Al-Tawfiq et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Characterization of Drug-Resistant Influenza A(H7N9) Variants Isolated From an Oseltamivir-Treated Patient in Taiwan
- (2014) Henju Marjuki et al. JOURNAL OF INFECTIOUS DISEASES
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
- (2014) John Mair-Jenkins et al. JOURNAL OF INFECTIOUS DISEASES
- An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality
- (2014) Henju Marjuki et al. JOURNAL OF INFECTIOUS DISEASES
- Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2
- (2014) Michael P. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Residues in the Human Respiratory Syncytial Virus Fusion Protein That Modulate Fusion Activity and Pathogenesis
- (2014) Anne L. Hotard et al. JOURNAL OF VIROLOGY
- Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial
- (2014) Jason Haffizulla et al. LANCET INFECTIOUS DISEASES
- Triple Immunoglobulin Gene Knockout Transchromosomic Cattle: Bovine Lambda Cluster Deletion and Its Effect on Fully Human Polyclonal Antibody Production
- (2014) Hiroaki Matsushita et al. PLoS One
- An In Vivo Human-Plasmablast Enrichment Technique Allows Rapid Identification of Therapeutic Influenza A Antibodies
- (2013) Gerald Nakamura et al. Cell Host & Microbe
- Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy
- (2013) Hisham Momattin et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
- (2013) Abdullah Assiri et al. LANCET INFECTIOUS DISEASES
- Characterization of H7N9 influenza A viruses isolated from humans
- (2013) Tokiko Watanabe et al. NATURE
- Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
- (2013) Darryl Falzarano et al. NATURE MEDICINE
- Middle East Respiratory Syndrome Coronavirus Infections in Health Care Workers
- (2013) Ziad A. Memish et al. NEW ENGLAND JOURNAL OF MEDICINE
- Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein
- (2013) Zhiwu Sun et al. Viruses-Basel
- RESPIRATORY TRACT INFECTIONS: Emerging viral pathogens
- (2013) ROY A. BORCHARDT et al. JAAPA-Journal of the American Academy of Physician Assistants
- Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice
- (2012) E. Bart Tarbet et al. ANTIVIRAL RESEARCH
- A Phase II Study of DAS181, a Novel Host Directed Antiviral for the Treatment of Influenza Infection
- (2012) R. B. Moss et al. JOURNAL OF INFECTIOUS DISEASES
- ALX-0171 toxicity study in RSV-infected cotton rats: Safety and therapeutic potential
- (2012) Gilles Hanton et al. TOXICOLOGY LETTERS
- Analysis of Respiratory Syncytial Virus Preclinical and Clinical Variants Resistant to Neutralization by Monoclonal Antibodies Palivizumab and/or Motavizumab
- (2011) Qing Zhu et al. JOURNAL OF INFECTIOUS DISEASES
- Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV)
- (2011) A. Bonavia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
- (2011) D. C. Ekiert et al. SCIENCE
- Pharmacokinetics-Pharmacodynamics of a Respiratory Syncytial Virus Fusion Inhibitor in the Cotton Rat Model
- (2010) M.-C. Rouan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influenza M2 proton channels
- (2010) Rafal M. Pielak et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181
- (2010) Gallen B. Triana-Baltzer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bronchiolitis: Recent Evidence on Diagnosis and Management
- (2010) J. J. Zorc et al. PEDIATRICS
- New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets
- (2010) Robert H. E. Friesen et al. PLoS One
- A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
- (2010) J. DeVincenzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in Mice
- (2009) D. F. Smee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Thiazolides: a new class of antiviral drugs
- (2009) Jean-François Rossignol Expert Opinion on Drug Metabolism & Toxicology
- DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis
- (2009) Gallen B. Triana-Baltzer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Thiazolides, a New Class of Anti-influenza Molecules Targeting Viral Hemagglutinin at the Post-translational Level
- (2009) Jean François Rossignol et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pre‐ and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir
- (2009) Wouter Koudstaal et al. JOURNAL OF INFECTIOUS DISEASES
- Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice
- (2009) Lia M. Haynes et al. JOURNAL OF INFECTIOUS DISEASES
- Solution structure and functional analysis of the influenza B proton channel
- (2009) Junfeng Wang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Motavizumab, a Humanized, Enhanced-Potency Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus Infection in At-Risk Children
- (2009) Katia Abarca et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein
- (2009) Gallen B. Triana-Baltzer et al. PLoS One
- Selection of a Respiratory Syncytial Virus Fusion Inhibitor Clinical Candidate. 2. Discovery of a Morpholinopropylaminobenzimidazole Derivative (TMC353121)
- (2008) Jean-François Bonfanti et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry
- (2008) M Frogel et al. Journal of Perinatology
- Structure and mechanism of the M2 proton channel of influenza A virus
- (2008) Jason R. Schnell et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now